Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

Press releases published on March 31, 2026

Mar. 31, 2026

Truveta deepens financial leadership with appointment of Henry Ford Health executive Robin Damschroder, FACHE as Board Chair

Indeterminate GlobeNewswire

Mar. 31, 2026

Truveta deepens health system leadership with appointment of Erik Wexler to Board of Directors

Indeterminate GlobeNewswire

Mar. 31, 2026

Berry Street Joins Amazon's Health Benefits Connector, Expanding Access to one of Healthcare's Most Underutilized Benefits

Indeterminate GlobeNewswire

Mar. 31, 2026

ZymoChem's BAYSE™ Becomes First Bio-Based Superabsorbent to Match and Outperform Petroleum-Based Materials

Indeterminate GlobeNewswire

Mar. 31, 2026

Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2025

Indeterminate GlobeNewswire

Mar. 31, 2026

Global Medtech CDMO Market Grows to $96.5B in 2025 as Pharma-Medtech Convergence Emerges as a Defining Accelerator

Indeterminate GlobeNewswire

Mar. 31, 2026

Just Salad Opens in Northbook, Ill.

Indeterminate GlobeNewswire

Mar. 31, 2026

American Kidney Fund’s Podcast, ‘The Kidney Collective,’ Debuts New Season on Rare Kidney Disease

Indeterminate GlobeNewswire

Mar. 31, 2026

Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026

Indeterminate GlobeNewswire

Mar. 31, 2026

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

Indeterminate GlobeNewswire

Mar. 31, 2026

PK Activation Gains Momentum in Thalassemia Agios’ Aqvesme Launch Reflects Strong Promise with Deliberate Uptake

Indeterminate GlobeNewswire

Mar. 31, 2026

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

Indeterminate GlobeNewswire

Mar. 31, 2026

Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1

Indeterminate GlobeNewswire

Mar. 31, 2026

PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA

Indeterminate GlobeNewswire

Mar. 31, 2026

Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

Indeterminate GlobeNewswire

Mar. 31, 2026

QHSLab (OTCQB:USAQ) Reports Strong Fiscal 2025 Results with Revenue Growth, Expanding Margins, and Significant Balance Sheet Improvement

Indeterminate GlobeNewswire

Mar. 31, 2026

Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease

Indeterminate GlobeNewswire

Mar. 31, 2026

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Indeterminate GlobeNewswire

Mar. 31, 2026

Vantive Presents New Data at WCN on How Coordinated Care Ecosystems Can Expand Home-Based Peritoneal Dialysis Access and Improve Patient Outcomes

Indeterminate GlobeNewswire

Mar. 31, 2026

MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation

Indeterminate GlobeNewswire